Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 4.23%11.47M | ---- | -54.90%11.01M | ---- | -39.19%24.41M | ---- | 254.61%40.14M | ---- | 326.22%11.32M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -502.11%-2M | ---- | -5,433.33%-332K | ---- | ---6K | ---- | ---- | ---- | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.33%276K |
| Dividend (income)- adjustment | ---- | -25.11%-583K | ---- | -27.67%-466K | ---- | 1.08%-365K | ---- | ---369K | ---- | ---- |
| Impairment and provisions: | ---- | 69.77%511K | ---- | 1,468.18%301K | ---- | -100.62%-22K | ---- | 2,041.92%3.58M | ---- | 158.19%167K |
| -Impairmen of inventory (reversal) | ---- | 146.06%406K | ---- | 81.32%165K | ---- | -97.40%91K | ---- | 12,389.29%3.5M | ---- | 107.93%28K |
| -Other impairments and provisions | ---- | -22.79%105K | ---- | 220.35%136K | ---- | -241.25%-113K | ---- | -42.45%80K | ---- | 110.61%139K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.73%3K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.73%3K |
| Depreciation and amortization: | ---- | 18.66%3.78M | ---- | -0.93%3.18M | ---- | -1.83%3.21M | ---- | 0.03%3.27M | ---- | 2.03%3.27M |
| Financial expense | ---- | 149.48%484K | ---- | -35.97%194K | ---- | 172.97%303K | ---- | --111K | ---- | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,253.85%-176K |
| Operating profit before the change of operating capital | ---- | -1.61%13.66M | ---- | -49.56%13.89M | ---- | -41.08%27.53M | ---- | 214.45%46.73M | ---- | 1,886.06%14.86M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 302.87%27.76M | ---- | -155.38%-13.68M | ---- | 183.15%24.71M | ---- | -337.87%-29.72M | ---- | 33.23%12.49M |
| Accounts receivable (increase)decrease | ---- | -279.32%-27.07M | ---- | 324.44%15.1M | ---- | 24.20%-6.73M | ---- | 29.39%-8.88M | ---- | -207.27%-12.57M |
| Accounts payable increase (decrease) | ---- | -331.35%-39.12M | ---- | 1,769.20%16.91M | ---- | 84.84%-1.01M | ---- | -144.31%-6.68M | ---- | 248.90%15.08M |
| Special items for working capital changes | ---- | 64.79%-25K | ---- | -172.45%-71K | ---- | 126.70%98K | ---- | -187.38%-367K | ---- | 126.91%420K |
| Cash from business operations | ---- | -177.14%-24.79M | ---- | -27.94%32.14M | ---- | 4,010.51%44.6M | ---- | -96.42%1.09M | ---- | 31.55%30.29M |
| Other taxs | ---- | 164.60%146K | ---- | 98.37%-226K | ---- | -4,025.00%-13.86M | ---- | -1,868.42%-336K | ---- | 575.00%19K |
| Special items of business | 110.28%2.31M | ---- | -241.20%-22.48M | ---- | 19,758.02%15.92M | ---- | -100.58%-81K | ---- | -41.31%13.87M | ---- |
| Net cash from operations | 110.28%2.31M | -177.23%-24.65M | -241.20%-22.48M | 3.82%31.91M | 19,758.02%15.92M | 4,004.01%30.74M | -100.58%-81K | -97.53%749K | -41.31%13.87M | 31.65%30.31M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 502.11%2M | ---- | 5,433.33%332K | ---- | --6K | ---- | ---- | ---- | ---- |
| Dividend received - investment | ---- | 25.11%583K | ---- | 27.67%466K | ---- | -1.08%365K | ---- | --369K | ---- | ---- |
| Purchase of fixed assets | ---- | -21.01%-167K | ---- | -97.14%-138K | ---- | -6.06%-70K | ---- | 84.79%-66K | ---- | 90.10%-434K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --1.79M | ---- | ---- | ---- | ---- |
| Other items in the investment business | -34.91%992K | ---- | 1,958.54%1.52M | ---- | -41.38%-82K | ---- | -56.76%-58K | ---- | 86.79%-37K | ---- |
| Net cash from investment operations | -34.91%992K | 265.91%2.42M | 1,958.54%1.52M | -68.50%660K | -41.38%-82K | 591.42%2.1M | -56.76%-58K | 169.82%303K | 86.79%-37K | 91.33%-434K |
| Net cash before financing | 115.76%3.3M | -168.25%-22.23M | -232.31%-20.96M | -0.79%32.57M | 11,496.40%15.84M | 3,021.10%32.83M | -101.01%-139K | -96.48%1.05M | -40.76%13.83M | 65.80%29.87M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -69.00%9.3M | ---- | -40.00%30M | ---- | --50M | ---- | ---- | ---- | 413.22%71.85M |
| Refund | ---- | 69.00%-9.3M | ---- | 40.00%-30M | ---- | ---50M | ---- | ---- | ---- | -413.22%-71.85M |
| Interest paid - financing | ---- | -149.48%-484K | ---- | 35.97%-194K | ---- | -172.97%-303K | ---- | 59.78%-111K | ---- | -69.33%-276K |
| Dividends paid - financing | ---- | 25.00%-4.2M | ---- | ---5.6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -43.70%-1.8M | ---- | 0.00%-1.25M | ---- | -114.34%-1.25M | ---- | 798.00%8.75M | ---- | 6.77%-1.25M | ---- |
| Net cash from financing operations | -43.70%-1.8M | 11.87%-7.22M | 0.00%-1.25M | -198.40%-8.2M | -114.34%-1.25M | -9.62%-2.75M | 798.00%8.75M | 7.25%-2.51M | 6.77%-1.25M | -3.01%-2.7M |
| Net Cash | 106.76%1.5M | -220.84%-29.46M | -252.28%-22.21M | -18.98%24.38M | 69.48%14.59M | 2,169.26%30.09M | -31.55%8.61M | -105.35%-1.45M | -42.84%12.58M | 76.50%27.17M |
| Begining period cash | -26.66%81.04M | 28.30%110.5M | 28.30%110.5M | 53.69%86.12M | 53.69%86.12M | -2.53%56.04M | -2.53%56.04M | 89.61%57.49M | 89.61%57.49M | 103.14%30.32M |
| Cash at the end | -6.50%82.54M | -26.66%81.04M | -12.34%88.29M | 28.30%110.5M | 55.79%100.71M | 53.69%86.12M | -7.74%64.64M | -2.53%56.04M | 33.92%70.06M | 89.61%57.49M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.